Dissertation > Excellent graduate degree dissertation topics show

The Effects of Atorvastatin on Expression of Osteopontin in Kidney of the Diabetic Rats Its Molecular Mechanism

Author: DuYong
Tutor: WangYuan;ZhouQing;ZuoLi
School: Anhui Medical University,
Course: Biochemistry and Molecular Biology
Keywords: Atorvastatin Diabetic rats Osteopontin p38MAPK
CLC: R587.2
Type: Master's thesis
Year: 2011
Downloads: 6
Quote: 0
Read: Download Dissertation


Objective: To investigate the effects of atorvastatin on expression of osteopontin in diabetic rats kidney and its regulation mechanism. Methods: 45 rats were divided into 4 groups affer they were feed one week, which were normal group, higt fat group, diabetic group and atorvastatin group. The normal group rats were feed normol diet. The diabetic group and the atorvastatin group rats were treated with streptozotocin by intraperitoneal injection(35mg/kg) after they were given 8-week’s high fat diet. After a week, the atorvastatin group rats were give atorvastatin 20mg/(kg?d). The blood and kidney were obtained after 8 weeks, serum glucose, triglyceride, cholesterol were analyzed. The renal pathologic injury was observed by HE stains. The expression of OPN and pp38 were detected by Western blot and immunohistochemical methods. The MDCK cells were stimulated with high-glucose DMEM(25mM glucose). At the same time, different consistency atorvastatin were used to stimulate the cell for 48 hours. After that, it was observed that change of OPN expression and p38 phosphorylation levels. Results The diabetic rats model was established successfully. Compared with normal group, serum glucose and cholesterol were significantly increased ( P <0.05, P <0.05) in diabetic group. Compared with diabetic group rats , serum cholesterol was significantly decreased (P <0.05). HE stains shows that DM rats has renal damege characterized by glomerular hypertrophy, mesargial regin, mild expansion of the mesangial matrix, and the renal capsule present a narrow fracture, compared with the normal group and the atorvastatin group. The tubule of diabetic group showed slight hypertrophy and apparent hydrops, and serious vacuolar degeneration. Inflammatory cell infiltration could be detected in tubule interstitial substance. The damege were released in atorvastatin group. Osteopontin’s expression is localized in nephric tubule epithelial cell in this study. The section with the anti-osteopontin showed a strong nucler positive signal in diatetic group. The osteopontin’s positive rate was significationly reduced in atorvastatin group. Atorvastatin markedly decreased cholesterol and kidney pathology damage. The expression of osteopontin and pp38/p38 was obviousily increased in diabetic group(P < 0.05), compared with normal group. And the immunohistochemistry and western blot results show that the reduction of expression of OPN and pp38 was significant compared with the diabetic group(P<0.05). In MDCK cells cultured in 25mM glucose DMEM, the expression of osteopontin wsa increased , compared with normal group(P<0.05). Which was decreased treated with atorvastatin compared with high glucose group(P<0.05). Conclusion Atorvastatin could decreased the level of Serum cholesterol and protect the kidney. Atorvastatin decreased the expression of osteopontin and pp38/p38 in diabetic rats renal. Atorvastatin maybe decrease the expression of osteopontin via p38/MAPK pathway.

Related Dissertations

  1. The Effect and Mechanism of p38MAPK Inhibitor CBS3830 on Intimal Hyperplasia in Autogenous Vein Grafts of Diabetic Rats,R587.1
  2. Early Responses of Bone Marrow Stem Cells to Different Mechanical Signals Through p38MAPK Signaling Pathway,R329
  3. Antioxidant Effects of Atorvastatin on Vascular Remodeling of Vascular Injury in Mice,R543
  4. The Myocardial Protection Effect of High-Dose Atorvastatin Pretreatment Before Percutaneous Coronary Intervention in Acute Coronary Syndrome,R541.4
  5. Role of Osteopontin and CD44 in Stone Formation,R691.4
  6. The Experimental Study of Atorvastatin with Neuroprotective Effects by Inhibiting MMP-9 and Upregulating TIMP-1 Expression in Rat Stroke Model of Focal Cerebral Ischemia/Reperfusion,R743.33
  7. Osteopontin through the MAPK signaling pathway and increased MMP9 expression correlation with embryo implantation,R321
  8. Effect and Mechanism of Atorvastatin on Myocardial Fibrosis in Rats after Myocardial Infarction,R542.22
  9. Expression and Correlation of Urokinase-type Plasminogen Activator (uPA) and Its Receptor (uPAR) and Mitogen Activated Protein Kinase (MAPK) p38 in Endometrial Carcinomas,R737.33
  10. Role of p38MAPK Signaling Pathways in the Apoptosis of C2C12 Myoblast Cells Subjected to Cyclical Stretch,R783.5
  11. The Plasma and Tissue Expression of Osteopontin and CD44v6 in Gastric Carcinoma and Their Significance,R735.2
  12. Different Doses of Atorvastatin Improve the Forward Blood Flow in the No-reflow Rats Associated with Inflammation,R541
  13. The Relationships among Osteopontin, Obesity and Insulin Resistance,R589
  14. Effects of Columbin on Hepatic Drug Metabolizing Enzymes CYP450 in Experimental Type 2 Diabetic Rats,R965
  15. The Expression of ER-associated Degradation Related Factors in the Retina of Diabetic Rats,R774.1
  16. Influence of Atrovastation on MMP-9 and TIMP-1 of Experimental Intracerebral Hemorrhage in Rats,R965
  17. Protective Effects of Atorvastatin on Vascular Endothelial Dysfunction Caused by Lysophosphatidyl Choline,R965
  18. Expression of Netrin-1 mRNA in the Retina of Diabetic Rats,R774.1
  19. Effects of OPN on MMP13 Expression of Human Osteoarthritic Chondrocyte in Vitro,R684.3
  20. Effects of Hyaluronic Acid on Osteopontin and CD44 of Fibroblast-like Synoviocytes in Patients with Osteoarthritis of the Knee,R684.3

CLC: > Medicine, health > Internal Medicine > Endocrine diseases and metabolic diseases > Islet disease > Diabetic coma and other complications
© 2012 www.DissertationTopic.Net  Mobile